Skip to main content
. 2023 Sep;27(9):655–662. doi: 10.5005/jp-journals-10071-24533

Table 2.

Characteristics of the study population

Characteristics N = 160
Median age (years) 58 (18–86)
Male 120 (75%)
Female 40 (25%)
Charlson comorbidity index (mean) 4
PITT bacteremia score (mean) 6
SOFA score (mean) 16
Prior exposure to a carbapenem 58 (36.25%)
Source of sepsis
 Line related 38 (23.75%)
 Unclear 36 (22.5%)
 Intra-abdominal 36 (22.5%)
 Pneumonia 22 (13.75%)
 Urinary 20 (12.5%)
 SSTI–Skin and soft tissue infection 7 (4.37%)
 Meningitis 1 (0.62%)
Organisms (n = 164)
Klebsiella pneumoniae 77 (46.95%)
Escherichia coli 39 (23.78%)
Enterobacter cloacae 6 (3.65%)
Citrobacter koseri 2 (1.22%)
Serratia marcescens 2 (1.22%)
Morganella morganii 1 (0.61%)
Acinetobacter baumannii 16 (9.75%)
Pseudomonas aeruginosa 7 (4.26%)
Pseudomonas stutzeri 1 (0.61%)
Pseudomonas putida 2 (1.22%)
Burkholderia pseudomallei 2 (1.22%)
Burkholderia cepacia 2 (1.22%)
Aeromonas hydrophila 3 (1.65%)
Ralstonia mannitolilytica 1 (0.61%)
Stenotrophomonas maltophilia 2 (1.22%)
Elizabethkingia meningoseptica 1 (0.61%)
Status on day 14
 Alive 109 (68.13%)
 Dead 44 (27.5%)
 Not known 7 (4.37%)
Status on day 30
 Alive 72 (45.00%)
 Dead 63 (39.37%)
 Not known 25 (15.62%)
No. of patients died 67 (41.87%)
Median time to death from index bacteremia (days) 9
Median time to Carba-R (hours:min) 30:34
Median time to routine DST (hours:min) 74:20